QTTB
Q32 Bio IncNASDAQHEALTHCAREBIOTECHNOLOGY
Key Statistics
Market Cap
$98.35M
P/E Ratio
2.09
EPS
$2.78
Beta
-1.27
52W High
$8.04
52W Low
$1.34
50-Day MA
$5.99
200-Day MA
$3.76
Dividend Yield
—
Profit Margin
61.90%
Forward P/E
—
PEG Ratio
—
About Q32 Bio Inc
Q32 Bio Inc. (QTTB) is an innovative biotechnology company specializing in the development of cutting-edge antibody-based therapies aimed at treating autoimmune diseases and optimizing immune responses. With its proprietary technology platform, Q32 Bio is advancing a diverse pipeline of therapeutic candidates poised to restore immune balance and address critical unmet medical needs. Supported by a highly experienced management team and strategic partnerships, Q32 Bio is strategically positioned to drive meaningful advancements in healthcare, ultimately creating long-term value for shareholders through its commitment to ongoing research and development excellence.
Fundamentals
| Revenue (TTM) | $53.74M |
| Gross Profit (TTM) | $38.49M |
| EBITDA | $21.77M |
| Operating Margin | 39.80% |
| Return on Equity | 157.20% |
| Return on Assets | 18.80% |
| Revenue/Share (TTM) | $4.21 |
| Book Value | $3.17 |
| Price-to-Book | 2.12 |
| Price-to-Sales (TTM) | 1.83 |
| EV/Revenue | 1.14 |
| EV/EBITDA | 1.71 |
| Quarterly Earnings Growth (YoY) | 0.00% |
| Quarterly Revenue Growth (YoY) | 0.00% |
| Shares Outstanding | $16.96M |
| Float | $9.69M |
| % Insiders | 3.93% |
| % Institutions | 59.75% |
Historical Volatility
HV 10-Day
101.36%
HV 20-Day
98.38%
HV 30-Day
98.29%
HV 60-Day
113.67%
HV Rank
—
Volatility is currently expanding
Analyst Ratings
Consensus ($14.25 target)
2
Buy1
HoldMore HEALTHCARE Stocks
Data last updated: 5/25/2026